HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

about

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

Item

http://www.wikidata.org/entity/Q47320133

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

@en

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

@nl

type

Item

label

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

@en

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

@nl

prefLabel

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

@en

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

@nl

P1476

HLAs: Key regulators of T-cell-mediated drug hypersensitivity

@en

P2093

E J Phillips

http://www.w3.org/2001/XMLSchema#string

K D White

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

Possible role of HLA in hepatotoxicity. An exploratory study in 71 patients with drug-induced idiosyncratic hepatitis

P304

3-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TAN.13183

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alec J Redwood

N J Pavlos

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29171940

http://www.w3.org/2001/XMLSchema#string

P932

5743596

http://www.w3.org/2001/XMLSchema#string